HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways

Oncotarget

Volumn 6, Issue 29, 2015, Pages 27778-27793

  Duan, Ran ^a,e   Han, Lei ^b,c,d,e   Wang, Qixue ^b,c,d,e   Wei, Jianwei ^b,c,d,e   Chen, Luyue ^b,c,d,e   Zhang, Jianning ^c,d,e   Kang, Chunsheng ^b,c,d,e   Wang, Lei ^a,e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Tianjin Binhai Neurological Institute   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^e Chinese Glioma Cooperative Group (CGCG)   (China)

Author keywords

Epithelial to mesenchymal transition (EMT); Glioma; Homeobox (HOX) gene; HOXA13; Smad

Indexed keywords

BETA CATENIN; ISOCITRATE DEHYDROGENASE 1; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA11; TRANSCRIPTION FACTOR HOXA9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; HOMEOBOX PROTEIN HOXA13; HOMEODOMAIN PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GLIOBLASTOMA; GROWTH INHIBITION; HOXA13 GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ONCOGENE; OVERALL SURVIVAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; AGED; ANIMAL; BIOLOGY; BRAIN TUMOR; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; GLIOMA; METABOLISM; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR CELL LINE; WNT SIGNALING PATHWAY; YOUNG ADULT;

ADULT; AGED; ANIMALS; APOPTOSIS; BETA CATENIN; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; COMPUTATIONAL BIOLOGY; CYTOPLASM; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WNT SIGNALING PATHWAY; YOUNG ADULT;

EID: 84944462984     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4813     Document Type: Article

References (35)

1. Qian YQ, Billeter M, Otting G, Muller M, Gehring WJ, Wuthrich K. The structure of the Antennapedia homeodomain determined by NMR spectroscopy in solution: comparison with prokaryotic repressors. Cell. 1989; 59:573-580.
2. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature. 1978; 276:565-570.
3. Akam M. Hox genes: from master genes to micromanagers. Curr Biol. 1998; 8:R676-R678.
4. Noordermeer D, Leleu M, Splinter E, Rougemont J, De Laat W, Duboule D. The dynamic architecture of Hox gene clusters. Science. 2011; 334:222-225.
5. Klein D, Benchellal M, Kleff V, Jakob HG, Ergün S. Hox genes are involved in vascular wall-resident multipotent stem cell differentiation into smooth muscle cells. Sci Rep. 2013; 3:2178.
6. Gehring WJ, Hiromi Y. Homeotic genes and the homeobox. Annu Rev Genet. 1986; 20:147-173.
7. Kappen C, Schughart K, Ruddle FH. Organization and expression of homeobox genes in mouse and man. Ann N Y Acad Sci. 1989; 567:243-252.
8. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z, Boldanova T, Andersen JB, Hämmerle M, Tornillo L, Heim MH, Diederichs S, Cillo C, et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2014; 59:911-923.
9. Bhatlekar S, Fields JZ, Boman BM. HOX genes and their role in the development of human cancers. Journal of Molecular Medicine. 2014; 92:811-823.
10. Richards EJ, Zhang G, Li ZP, Permuth-Wey J, Challa S, Li Y, Kong W, Dan S, Bui M, Coppola D, Mao WM, Sellers TA, Cheng JQ. Long non-coding RNAs regulated by TGF-ß: lncRNA-HIT mediated TGFbeta-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem. 2015.
11. Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, Reis RM, Costello JF. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res. 2010; 70:453-462.
12. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, Hainfellner JA, Heppner FL, Dietrich PY, Zimmer Y, Cairncross JG, Janzer RC, et al. Stem cell-related ''self-renewal'' signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol. 2008; 26:3015-3024.
13. Gaspar N, Marshall L, Perryman L, Bax DA, Little SE, Viana-Pereira M, Sharp SY, Vassal G, Pearson AD, Reis RM, Hargrave D, Workman P, Jones C. MGMTindependent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature. Cancer Res. 2010; 70:9243-9252.
14. Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, Yu SZ, Pu PY, Liu N, You YP, Jiang T, Kang CS. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro-Oncology. 2013; 15:1595-1603.
15. Zhang K, Sun X, Zhou X, Han L, Chen L, Shi Z, Zhang A, Ye M, Wang Q, Liu C, Wei J, Ren Y, Yang J, et al. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget. 2015; 6:537-46.
16. van den Bent M, Chinot OL, Cairncross JG. Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro-Oncology. 2003; 5:128-138.
17. Kalpathy-Cramer J, Gerstner ER, Emblem KE, Andronesi OC, Rosen B. Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma. Cancer Res. 2014; 74:4622-4637.
18. Pan T, Jia W, Yao Q, Sun Q, Ren W, Huang M, Ma J, Li J, Ma J, Yu J, Ge Y, Liu W, Zhang C, Xu G. Overexpression of HOXA13 as a Potential Marker for Diagnosis and Poor Prognosis of Hepatocellular Carcinoma. The Tohoku Journal of Experimental Medicine. 2014; 234:209-219.
19. Han Y, Tu W, Wen Y, Li D, Qiu G, Tang H, Peng Z, Zhou C. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry. Medical Oncology. 2013; 30.
20. Zhao J, Zhang L, Guo X, Wang J, Zhou W, Liu M, Li X, Tang H. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells. IUBMB Life. 2015; 67:380-394.
21. He Z, Jiang J, Kokkinaki M, Dym M. Nodal Signaling via an Autocrine Pathway Promotes Proliferation of Mouse Spermatogonial Stem/Progenitor Cells Through Smad2/3 andOct-4 Activation. Stem Cells. 2009; 27:2580-2590.
22. Sengupta S, Jana S, Bhattacharyya A. TGF-ß-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Cellular Signalling. 2014; 26:240-252.
23. Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W, Zheng S, Zhuang B, Chen H, Li W, Li H, Li H, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Journal of Translational Medicine. 2015; 13.
24. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial- Mesenchymal Transitions in Development and Disease. Cell. 2009; 139:871-890.
25. Song J. EMT or apoptosis: a decision for TGF-beta. Cell Res. 2007; 17:289-290.
26. Holtzhausen A, Golzio C, How T, Lee YH, Schiemann WP, Katsanis N, Blobe GC. Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development. The FASEB Journal. 2014; 28:1248-1267.
27. Dai F, Duan X, Liang YY, Lin X, Feng XH. Coupling of dephosphorylation and nuclear export of Smads in TGFbeta signaling. Methods Mol Biol. 2010; 647:125-137.
28. Massague J. Smad transcription factors. Genes & Development. 2005; 19:2783-2810.
29. Liu S, Jin K, Hui Y, Fu J, Jie C, Feng S, Reisman D, Wang Q, Fan D, Sukumar S, Chen H. HOXB7 promotes malignant progression by activating the TGFbeta signaling pathway. Cancer Res. 2015; 75:709-71927778-27793.
30. Williams TM. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability. Nucleic Acids Research. 2005; 33:4475-4484.
31. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113:685-700.
32. Clevers H, Nusse R. Wnt/ß-Catenin Signaling and Disease. Cell. 2012; 149:1192-1205.
33. Shi Z, Qian X, Zhang J, Han L, Zhang K, Chen L, Zhou X, Zhang J, Kang C. BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA-mediated. CNS Neuroscience & Therapeutics. 2014; 20:830-839.
34. Shi Z, Qian X, Liu C, Han L, Zhang K, Chen L, Zhang J, Pu P, Yuan X, Kang C. Aspirin-/TMZ-coloaded Microspheres Exert Synergistic Antiglioma Efficacy via Inhibition of ß-catenin Transactivation. CNS Neuroscience & Therapeutics. 2013; 19:98-108.
35. Zhang K, Zhang J, Han L, Pu P, Kang C. Wnt/beta- Catenin Signaling in Glioma. Journal of Neuroimmune Pharmacology. 2012; 7:740-749.